These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26993476)

  • 21. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
    Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
    World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
    Ohtaki Y; Shimizu K; Kaira K; Nagashima T; Obayashi K; Nakazawa S; Kakegawa S; Igai H; Kamiyoshihara M; Nishiyama M; Takeyoshi I
    Surg Today; 2016 Oct; 46(10):1196-208. PubMed ID: 26782692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary lymphoepithelioma-like carcinoma of the lung: distinct computed tomography features and associated clinical outcomes.
    Mo Y; Shen J; Zhang Y; Zheng L; Gao F; Liu L; Xie C
    J Thorac Imaging; 2014 Jul; 29(4):246-51. PubMed ID: 24463405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computed tomography-based differentiation of primary pulmonary lymphoepithelioma-like carcinoma and small-cell lung cancer.
    Lee KL; Wu MH; Jhang YY; Chen CK; Yen YC; Chen YC
    J Chin Med Assoc; 2020 Oct; 83(10):936-942. PubMed ID: 33017126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung.
    Liu Q; Ma G; Yang H; Wen J; Li M; Yang H; Luo K; Hu Y; Fu J
    Thorac Cancer; 2014 Jan; 5(1):63-7. PubMed ID: 26766974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association of epstein-barr virus with lymphoepithelioma-like carcinoma of the lung].
    Han A; Xiong M; Zong Y
    Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):222-4. PubMed ID: 10072868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients.
    Samejima J; Nakao M; Matsuura Y; Uehara H; Mun M; Nakagawa K; Motoi N; Masuda M; Ishikawa Y; Okumura S
    Jpn J Clin Oncol; 2015 Nov; 45(11):1050-4. PubMed ID: 26355162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of surgical treatment for non-small cell lung cancer with positive sputum cytology: experience from a single institution.
    Kozu Y; Maniwa T; Takahashi S; Isaka M; Ohde Y
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):588-92. PubMed ID: 24590474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer Patients.
    Yamaguchi M; Edagawa M; Suzuki Y; Toyozawa R; Hirai F; Nosaki K; Seto T; Takenoyama M; Ichinose Y
    Ann Thorac Surg; 2017 May; 103(5):1594-1599. PubMed ID: 27863731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer.
    Takenaka T; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Seto T; Takenoyama M; Ichinose Y
    Surg Today; 2016 Apr; 46(4):430-6. PubMed ID: 26070907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer.
    Park S; Choi MG; Kim KM; Kim HS; Jung SH; Lee JH; Noh JH; Sohn TS; Bae JM; Kim S
    J Surg Res; 2015 Apr; 194(2):458-463. PubMed ID: 25592274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.